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Myoepithelial carcinoma is a rare malignancy of the parotid gland that is usually seen in adults. We report the first case in
children of myoepithelial carcinoma of the parotid gland with massive invasion of the facial nerve and metastasis to cervical
lymph nodes. Due to its rarity, the treatment and the clinical course of this tumor are not well defined yet. We performed a total
parotidectomy, a modified neck dissection, and a postoperative radiotherapy in 7-year-old boy. Sparing of the facial nerve was
impossible; it was sacrificed and grafted with a sural nerve. Histopathology confirmed the diagnosis of a parotid gland carcinoma
and immunohistochemical markers showed that the tumor cells express cytokeratin, epithelial membrane antigen, cytokeratin
7, smooth muscle actin, P63, CEA, and S100. This pattern of immunostaining is consistent with the diagnosis of myoepithelial
carcinoma. On the postoperative tenth month he presented with a pulmonary and lumbar vertebra metastasis.
1. Introduction
Sheldon was the first to identify myoepithelial salivary gland
tumor as a distinct neoplastic entity in 1943 [1] and it was
first described by Stromeyer et al. in 1975 [2]. Coupled with
the rarity of this lesion, the diagnosis is further complicated
by the considerable variability in morphologic features
and clinical prognosis. Myoepithelial carcinoma has been
included in the World Health Organization classification
of salivary gland tumors since 1991 [3]. Myoepithelial
carcinoma of the parotid gland represents less than 5% of all
salivary gland tumors. Due to its rarity, the treatment and
clinical course of this tumor are not well defined yet. We
report the first case of myoepithelial carcinoma of the parotid
gland in children with massive invasion of the facial nerve
and metastasis to cervical lymph nodes.
2. Case Presentation
A 7-year-old boy was referred to our department for the
evaluation of a mass in the left upper cervical region. The
child described a painless tumor that had been progressively
increased in size for the last six months without any
associated symptoms. The child was known to be healthy,
vaccinated without any specific medical problems. Physical
examination showed a soft, deep, and immobile, noninflam-
matory, 3.0 × 2.5 × 2.0 cm left parotid mass associated with
left facial paresis grade III (House-Brackmann classification).
Multiple left upper cervical enlarged lymph nodes were
noticed. The largest one reaching 2.0× 2.0× 2.0 cmwas hard
and mobile.
The remaining otolaryngology exam was within normal
limits. Serologies for Epstein-Barr virus, cytomegalovirus,
Bartonella henselae as well as tuberculin PPD test (purified
protein derivative) were all negative. Cervical magnetic reso-
nance imaging (MRI) (Figure 1) showed a large tumor with
heterogeneous signals of left parotid gland with multiple
necrotic areas, associated with multiple jugulodigastric and
retrocervical lymph nodes. A fine-needle aspiration (FNA)
revealed atypical cells without a definite diagnosis; open
biopsy of the cervical lymph nodes showed a metastatic
carcinoma consistent with myoepithelial carcinoma of sali-
vary gland origin. Additional workup including chest X-ray,
brain MRI, and a computerized tomography (CT) scan of
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Figure 1: Coronal T1-weighted (a) and axial T2-weighted (b) cervical magnetic resonance imaging showing a parotid gland tumor with a
heterogeneous signals with a central area of necrosis (arrow).
>
>
Figure 2: Low-magnification view of representative histopathology
field of the lesion. Tumor shows epithelioid and spindled cells with
central zone of necrosis (Arrow heads). (H&E 10x).
the abdomen were within normal limits. Subsequently the
patient was planned for surgery.
Left total parotidectomy with modified neck dissection
of the cervical areas I, II, III, and IV was performed. The
tumor was of 3.0 × 2.5 × 2.0 cm lobulated, dark red color
invading the superficial and deep lobes of the parotid gland.
The main trunk of the facial nerve and its subdivisions were
totally invaded by the tumor. Thus sacrificing the facial nerve
was necessary for a one-block excision of the tumor. A left
sural nervous graft of 8 cm, with two branches (Y shape),
was grafted between the main trunk proximally and the
mandibular as well as the zygomatic branch distally. The
accessory nerve, internal jugular vein, and the sternoclei-
domastoid muscle were preserved. A frozen section of the
parapharyngeal fat was negative for malignancy.
The patient had an uneventful postoperative course and
was discharged home on the fourth postoperative day with a
total left facial nerve paralysis.
Histopathology showed a 3.0 × 2.5 × 3.0 cm high-grade
myoepithelial carcinoma (Figure 2) replacing most of the
gland, extending to the extraglandular tissues, invading the
facial nerve with lymphatic vascular invasion. The margins
were free of tumor. Metastatic carcinoma was present in 7 of
14 periglandular nodes and in 6 of 47 left cervical nodes.
The tumor was composed of nests and sheets of spindled
and epithelioid cells with areas of necrosis. Immunostains
showed that the tumor cells express cytokeratin, EMA,
cytokeratin 7, smooth muscle actin, P63, CEA, and S100
and are negative for desmin, LCA, CD34, and CD20. This
pattern of immunostaining is consistent with the diagnosis
of myoepithelial carcinoma.
Because of the aggressiveness of this tumor, the patient
underwent postoperative radiotherapy, despite the lack of
clear guidelines in the literature. MRI and whole body
positron emission tomography (PET) scan performed six
months later were normal. Unfortunately, on the postoper-
ative tenth month, the patient presented a pulmonary and
lumbar vertebra metastasis.
3. Discussion
Myoepithelial carcinomas are usually known as a soft tissue
tumor all over the body. Salivary glands myoepithelial
carcinomas occur in adults at a mean age of 55 years [4].
To our best knowledge, only one case of myoepithelial
carcinoma of the parotid gland has been reported in children
[5]. However, we report the first case of parotidmyoepithelial
carcinoma which is associated to a massive invasion of
the facial nerve, to a cervical lymph nodes metastasis and
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complicated by a pulmonary and lumbar vertebra metastasis
in a 7 year-old boy.
Pediatric salivary gland neoplasms are malignant in 33%
of cases compared to 20% of adult salivary gland tumors
[6]. Female-to-male ratio is 2 : 1. In contrast to adults, the
larger the gland is, the higher the likelihood of malignancy
in children is. Therefore, 85% of salivary gland malignancies
found in children originate in the parotid gland [7]. Thus
a child who presents with a firm parotid mass should be
suspected of harboring a malignancy.
Malignant salivary gland neoplasm’s usually present as a
painless swelling but they are more frequently symptomatic
than benign lesions: facial nerve paresis (10 to 15%), pain (10
to 29%), and fixation of themass to the underlying structures
are themost presented symptoms. They usually indicate local
or regional tumor extension [8].
MRI is well known to be the preferred imaging study
to evaluate salivary gland masses. It shows the margins of
the tumor more sharply than does the CT scan. MRI is
especially helpful in case of facial nerve infiltration where it
gives an abnormal enhancement of the invaded segment and
an increase in nerve diameter [9].
PET scan is more sensitive (86%) but less specific (75%)
than either CT or MRI (57% sensitivity and 92% speci-
ficity) in detecting micrometastasis and in diﬀerentiating
tumor from postirradiation changes [10–13]. In addition,
PET scanning still lacks resolution to define margins of
involvement so it is of little use in assessing tumor extension.
Fine-Needle Aspiration (FNA) is a minimally invasive
procedure. Reports of FNA in children are encouraging,
citingminimal discomfort and no need for general anesthesia
[14]. It may allow rapid diagnostic and obviate the need
for open biopsy. In cases of parotid mass where FNA
is inconclusive, the minimal procedure for diagnosis and
treatment of a solitary parotid mass should be a superficial
parotidectomy with facial nerve sparing.
The histological spectrum of salivary gland neoplasms
in the pediatric age group is similar to that of the adult
population. However, the incidence of the diﬀerent types
is not the same. Myoepithelial carcinoma constitutes less
than 2% of salivary gland carcinoma. Distinction between
malignant and benign myoepitheliomas may sometimes be
diﬃcult. The relative lack of cytological atypia distinguishes
these tumors from myoepithelial carcinomas [4]. Originally
classified as mixed tumors, the majority of myoepithelial
carcinomas develop in a pleomorphic adenoma [7]; in these
cases they are mainly low-grade malignancies [15]. When
they appear in isolated form or de novo, as in our case, the
carcinoma is often high grade [16]. Immunohistochemical
studies of myoepithelial carcinomas show that these tumors
usually express epithelial markers (cytokeratin and epithelial
membrane antigen) and to varying extent markers of
smooth muscle diﬀerentiation such as calponin (75%) and
smooth muscle actin (50%). Other markers are expressed in
varying degrees: S-100 protein (100%), Vimentin (100%),
and gliofibrillary protein acid (31%). The most sensitive
myogenic marker in a series of 29 myoepithelial carcinoma
of soft tissues was calponin (positive in 100% of the cases),
but this antibody has little specificity, as it is also expressed
in other tumors showing smooth muscle or myofibroblastic
diﬀerentiation [4]. Seethala et al. found the recently devel-
oped antibody P63 to be the best myoepithelial marker [17].
Owing to its rarity, there are yet no clear guidelines for
the management of myoepithelial carcinoma. For localized
salivary gland tumors, wide surgical excision is the mainstay
of therapy, and adjuvant radiation therapy with or without
cervical lymph node dissection is frequently preformed [4,
18]. The use of radiation therapy in combination with
surgery has improved the locoregional control and survival
rate for patients with major salivary glands carcinoma [19,
20]. The issue of postoperative radiation therapy in the
pediatric population is controversial, in light of the inherent
risk to develop a second malignancy. Complications related
to radiation therapy are not trivial, with one study reporting
a 60% rate of sequelae such as dental caries, prolonged tris-
mus, facial deformity, and osteoradionecrosis. Postoperative
radiation therapy is suggested for high-grade malignancy,
microscopic residual tumor, perineural invasion, soft-tissue
extension, or positive lymph nodes in multiple levels and
after salvage surgery. Few clinical reports are found in
the literature with respect to adjuvant chemotherapy for
malignant salivary neoplasms and especially myoepithelial
carcinoma [4].
Regarding facial nerve involvement, there was only mild
weakness in our case despite the massive tumor invasion
similar to the other reported case [5]. This might be due
to the persistence of an intact intratumoral nerve fibers.
Because high-grade malignancies are extremely uncommon
in children, preservation of the facial nerve should be the rule
unless it is invaded by the tumor. However there is yet no
consensus regarding sparing or not of the facial nerve in case
of myoepithelial carcinoma [7, 21, 22]. Parents should always
be counseled regarding the risk of facial nerve injury and
the need to sacrifice the nerve if the intraoperative findings
suggest tumor invasion or the preoperative biopsy confirms
a high-grade malignancy. Perineural spread may occur in an
axial and a circumferential pattern along the involved nerves;
retrograde tumor spreading allows the tumor to reach the
temporal bone and a skull base invasion.
The prognosis of malignant salivary neoplasm in the
pediatric population depends on the tumor type and grade.
In the most common salivary gland malignancy (Mucoepi-
dermoid Carcinoma), relapse rates for high-grade tumors
are 30% to 50% after a parotidectomy and enucleation,
respectively [7]. According to Terhaard et al., facial nerve
paralysis secondary to salivary neoplasms is associated with
high incidence of regional and distant metastases [23]. Fac-
tors suggesting a poor prognosis are facial palsy, pain, rapid
tumor growth, and the presence of ipsilateral lymph node
enlargement in the cervical region. However, an ordinary-
appearing clinical presentation could be falsely reassuring.
Overall, myoepithelial carcinomas in children seem to
have a somewhat more aggressive clinical course than those
in adults. Aggressive treatment as well as close and pro-
longed clinical and radiological followup are recommended
regarding the aggressiveness of the tumor and its unknown
behavior. Careful case assessment must include an atten-
tion to clinical presentation, intraoperative findings, and
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histopathologic features to ensure that the correct diagnosis
is established.
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